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Background: Europe overall suffered greatly in the early stages of the COVID-19
pandemic but the impact of different countries varied. Italy was in the forefront, but there
too there were differences, with the Lombardy region the epicentre of the pandemic.
Methods: We report Crude Mortality Rates (CMRs) from deaths reported as due to
COVID-19 and, in five countries where age-specific data are available, Standardized
Mortality Rates (SMRs) in the European Union and United Kingdom.
Results: As of 30th August 2020, Belgium was the country with the highest
cumulative CMR (86.3/100,000), but the Lombardy region reached almost double this
figure (167.6/100,000), far ahead of the corresponding figure for the rest of Italy at
37.0/100,000. SMRs could be calculated for five countries (Italy, Portugal, Sweden,
Germany, and Netherlands). Among them, Sweden had the highest SMR (61.6/100,000).
The corresponding figures for Italy, Netherlands, Portugal and Germany were 50.2, 41.4,
15.9, and 10.1 per 100,000, respectively.
Conclusion: It is clear that countries within Europe have performed very differently in
their responses to the COVID-19 pandemic, but the many limitations in the available data
must be addressed before a definitive assessment of the reasons for these differences
can be made.
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BACKGROUND
Europe was the continent worst affected in the initial phase of the SARS-CoV-2 pandemic. The first
cases in Europe were in Italy and deaths were soon rising rapidly in several of its northern regions,
especially Lombardy (1). As they watched graphic scenes of Italian hospitals struggling to cope,
European governments adopted a series of unprecedented measures to contain the spread of the
virus, althoughwith differing speed and intensity. These included restrictions onmovement outside
the home, rules on physical distancing, mandatory face covering in closed public settings, and
introduction of elements of find, test, trace, isolate, and support systems. Even where restrictions
were minimal, as in Sweden, or delayed, as in the United Kingdom, many people changed their
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behaviour in ways that reduced risks (2). Unlike the situation in
Africa and the Americas, the initial peak of infection in Europe is
now subsiding, and while some countries are seeing a resurgence
associated with loosening of restrictions, it is timely to take stock
of how Europe has fared in terms of deaths.
The impact of the pandemic can be measured several ways,
with the two main outcomes reported being incident infection
and mortality, both of which can be expressed in different
ways, including trends over time and cumulatively. Both are
sensitive to case definitions, which in turn are influenced by
the extent of testing. Mortality rates are also affected by how
the data are collected, with several countries operating separate
systems collecting information from hospitals and/or long term
care facilities to provide rapid information on emerging trends
alongside their existing vital registration systems that allow for
greater scrutiny of causes of death; definitions can vary, even
within countries, in how a death from COVID-19 is defined,
such as whether it is a death in someone who ever had a positive
test, had one within a defined period before death, or did not
have a test but had symptoms consistent with COVID-19 (3).
As a consequence, excess all-cause mortality is widely viewed
as the gold standard, with a recent study providing a detailed
examination of 21 industrialised countries (4). It has benefits and
drawbacks, as it includes deaths indirectly related to SARS-CoV-
2, such as those resulting from overstretched health facilities,
but it will also underestimate SARS-CoV-2 related deaths as
there may be reductions in deaths from, for example, road
traffic injuries.
In practice, most media and political attention has focused
on reports of deaths attributed to COVID-19 in official reports.
Yet their presentation often demonstrates a lack of even
basic epidemiological understanding, for example as they are
presented as numbers and not rates, and even less often as age-
standardised rates. Given their widespread use, but recognizing
their limitations, we have brought together the available data for
EU countries plus the United Kingdom (UK), calculating where
possible age standardized mortality rates (SMRs), and examining
the situation now and cumulatively.
METHODS
We conducted an observational ecological study, comparing
crude mortality rates (CMRs) and (SMRs) among EU countries
and the UK. We focused on these two indicators as they best
capture the trajectories of the pandemic and the impact of
responses of different countries. We also examine the particular
situation in Lombardy, the Italian region that was the first to
report COVID-19 cases in Europe.
We obtained the absolute number of COVID-19 deaths in
each EU country plus the UK as of August, 30th from the
European Centre for Disease Prevention and Control (ECDC)
(5).We calculated (CMRs) for COVID-19 using the daily number
of deaths/100,000 resident population. We were only able to
calculate SMRs for countries reporting identical age ranges (0–
9, 10–19, 20–29, 30–39, 40–49, 50–59, 60–69, 70–79, >80) of
COVID-19 deaths (Italy, Germany, Netherlands, Sweden, and
Portugal), which we obtained from national data sources (6–10).
To capture the overall burden of mortality officially attributed
to COVID-19 we calculated CMRs based on cumulative deaths
from 22nd February until 30th August, as reported to the
ECDC and, for the five countries with age-specific data in
national data sources, the age standardized cumulative figures.
In the latter case, age-stratified data were available only between
March 11th up to August 16th. When computing the crude
mortality rates, we undertook two analyses, one including and
one excluding the Lombardy region (10 million inhabitants),
which was the epicentre of the Italian COVID-19 epidemics.
As we were unable to use indirect standardization to compare
all countries due to data limitations, we calculated the SMR by
dividing the number of observed deaths in each country by the
expected number of deaths. The expected deaths were estimated
by multiplying the age-specific population in each country by
the age-specific mortality rate of the standard population. The
standard population was the total population of the EU (11).
We were unable to calculate the standardized death rates in
Lombardy alone, as data on age at death from COVID-19 were
not publicly available.
RESULTS
As of 30th August, the CMR for COVID-19 varied greatly
across EU countries, with Belgium reporting the highest
value (86.3/100,000), followed by the UK (68.5/100,000)
and Spain (62.1/100,000), while Slovakia had the lowest
(0.6/100,000) (Figure 1A). When considering Lombardy
region on its own, the CMR was almost twice that of
Belgium, with 167.6/100,000 in Lombardy vs. 37.0/100,000
for the rest of the country (Figure 1A). Among the five
countries where we could estimate age-standardised rates,
Sweden reported the highest, with a SMR of 61.6/100,000,
followed by Italy (50.3/100,000), Netherlands (41.4/100,000),
Portugal (15.9/100,000), and Germany (10.1/100,000)
(Figure 1B).
Turning to mortality trends, Lombardy region experienced
the earliest steep increase in Europe, with death rates increasing
from 0.2/100,000 on 1st March to 82.6/100,000 on 1st April.
The worst affected of the remaining EU countries and
the UK only increased steep increases in CMRs from the
beginning of April until the beginning of May, with Belgium
experiencing the highest increase among the 28 countries
(from 12.0/100,000 to 68.7/100,000) in this period, followed
by UK (from 3.7/100,000 to 39.9/100,000) and Spain (from
17.4/100,000 to 52.9/100,000). The CMR in Sweden showed
a consistent increase from the beginning of April until
the end of July (from 2.8/100,000 to 56.4/100,000) and it
plateaued only in the second half of August (56.9/100,000)
(Figure 2A).
When looking at cumulative SMRs, the trends were similar
for Italy and the Netherlands (0.9/100,000 and 0.0/100,000
on 11th March, 40.9/100,000 and 36.4/100,000 on 11th May,
48.2/100,000, 41.0/100,000 on 21st July, 50.3/100 000 and
41.4/100,000 on 16th August, respectively) where the plateau was
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FIGURE 1 | Crude Mortality Rates (A) for COVID-19 in 27 EU Countries plus UK, and Standardized Mortality Rates (B) (×100,000 inhabitants) at August, 2020.
FIGURE 2 | Cumulative Crude Mortality Rates (×100,000 inhabitants) for COVID-19 in 27 EU Countries plus UK (A), and Cumulative Standardized Mortality Rates
(×100,000 inhabitants) for selected EU Countries (B).
reached at the beginning of June (Figure 2B). Similar trends,
although with lower values, were also observed for Germany
and Portugal (both 0.0/100,000 on 11th March, 8.1/100,000 and
10.1/100,000 on 11thMay, 10.0/100,000 and 15.1/100,000 on 21st
July, 10.1/100,000 and 15.9/100,000 on 16th August, respectively)
with the plateau reached in the second half of May in Germany,
and in the first half of June in Portugal. Reflecting the trends
mentioned above, as of 16th August, Sweden has not yet reached
a plateau, experiencing a constant increase (0.0/100,000 on 11th
March, 32.4/100,000 on 11th May, 60.7/100,000 on 21st July and
61.6/100,000 on 16th August).
DISCUSSION
Before discussing our findings, it is necessary to note some
limitations, not least because they have implications for policy.
It seems remarkable that, in the face of a common threat that
has had an enormous impact on the burden of disease in Europe,
the routine hospital services (12) and the economy, governments
have been unable to develop a shared understanding of what
is being measured or to ensure that there are systems in place
to measure it accurately and report it in a timely way. The
ECDC has performed remarkably in collating and presenting
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the available data but it is constrained by what is collected by
national and regional governments. Given that this will not be
the last pandemic, this is something that should be addressed as
a priority.
Our analysis does, however, have some important strengths.
First, it does adjust for the age distribution of populations in
some countries, rendering themmore comparable, although even
where we had age-specific data, the early reports from some
countries had around 5–10% of missing values for age. Second,
by waiting until the initial peaks had subsided, it is possible
to compare the overall impact. This is a function of both the
height of the peak and the time that the rate remained elevated.
The importance of this can be illustrated by the situation in
Lombardy. Initially there was some debate about how it had
fared. Thus, despite the scenes of struggling hospitals, its death
rate 30 days after the onset of the epidemic was well-below
the corresponding figures in the Community of Madrid and in
Brussels (41.4/100,000 in Lombardy vs. 77.1 and 48.6/100,000,
respectively) (13). Yet it can now be seen that Lombardy has
experienced overall the highest COVID-19 mortality rates in
Europe (14). There are several possible reasons: it was the first
region to be affected in Europe, at a time when there was
little understanding how to manage this new illness. Lombardy
adopted a hospital-centred approach, in contrast to neighbouring
regions (45% of COVID-19 patients hospitalized versus 22%
of other Italian regions) (15), its intensive care units were
overwhelmed (16), and its nursing homes accommodated many
elderly frail patients (17). The first COVID-19 clusters in the
Netherlands, Germany, and Portugal started between one and
two-weeks later than in Italy, by which time they had seen
what was happening in Lombardy. Germany stands out from
other countries. A plausible explanation relates to its much
greater ICU capacity, with 29.2 beds/100,000 population in
Germany vs. 8.4/100,000 in Italy, 4.2/100,000 in Portugal, and
6.4/100,000 in the Netherlands at the onset of the epidemics
(16, 18). Sweden also stands out. Although it had made some
recommendations about interpersonal distancing, it rejected
many of the restrictions imposed elsewhere. At the time,
advocates of the Swedish approach suggested that this would
lead to a degree of immunity that would protect the country
against subsequent waves but it is now clear that this was not the
case (19).
The limitations of the data available for this analysis point to
the need for future work by researchers and others. European
governments and international agencies, including EUROSTAT
and the WHO must find ways to collate and rapidly publish data
on age at death for major causes. It is clear that the lethality
of this disease increases with increasing age. Yet there is little
information about whether this increase is the same everywhere.
This is important information that could offer insights to
inform policy but the data are lacking. More contentious, but
as important, is the almost complete lack of data on mortality
by ethnicity (the UK is a rare exception), so once again it is
impossible to understand the scale and nature of inequalities
within countries (20). Without this information, the scope for
cross national learning is limited.
The COVID-19 pandemic is far from over. Already, it is clear
that some countries have responded better than others. It is
beyond the scope of this paper to determine why and as several
countries are already experiencing a resurgence of cases, any
definitive assessment would be premature. However, answers are
likely to lie in three areas, political decision making, scientific
advice, and health system and public health capacity (21). For
now, in order to face the second wave of COVID-19, there is
an urgent need to put in place systems that can provide timely,
complete, and internationally comparable data (22).
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